Medline
MDLN
37.04
-0.80
-2.11%
Medline
US · MDLN
#667 by market cap
Listed 2025
37.04
-0.80
-2.11%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 3 in the most recent period (2026/Q4).
- Total institutional ownership fell 4.6 percentage points.
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 119.89% -4.60pp
- Institutions
- 506 -3
- As of
- 2026/Q4 vs. prior period
Holder types
VC/PE Fund47.17%
Mutual Fund45.21%
Sovereign Wealth Fund14.17%
Hedge Fund8.66%
Public Company1.63%
Private Company1.42%
Government Pension Fund1.32%
Individual/Insider1.11%
Family Office/Trust0.16%
Top holders as of 2026-09-30
The Carlyle Group Inc.
21.29% · 187.08M sh
Blackstone Inc.
17.45% · 153.33M sh
GIC Private Limited
8.49% · 74.63M sh
Hellman & Friedman LLC
8.07% · 70.87M sh
Capital Research
5.51% · 48.40M sh
FMR
4.96% · 43.56M sh
Abu Dhabi Investment Authority
4.71% · 41.36M sh
Invesco Ltd.
4.53% · 39.82M sh
Vanguard Capital Management, LLC
3.18% · 27.97M sh
BlackRock
3.02% · 26.55M sh
Lone Pine Capital LLC
2.39% · 20.97M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 20 buys · 30 sells
| Name | Role | Stake |
|---|---|---|
| The Carlyle Group Inc. | -- | 21.29% |
| Blackstone Inc. | -- | 17.45% |
| Charles Mills | Chairperson | 0.30% |
| GIC Private Limited | -- | 10.68% |
| Andrew Mills | Director | 0.30% |
| Patrick Healy | Independent Director | 0.18% |
| James Pigott | Former President | 0.14% |
| James Boyle | Chief Executive Officer | 0.06% |
| Michael Drazin | Chief Financial Officer | 0.06% |
| Douglas Golwas | Chief Commercial Officer | 0.06% |
| Stephen Miller | Former Chief Operating Officer | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-07 | GIC Private Limited | -- | Open Market Disposition | -7,816,987 | $35.15 |
| 2026-10-05 | GIC Private Limited | -- | Private Disposition | -16,418,941 | $34.33–35.05 |
| 2026-10-04 | GIC Private Limited | -- | Open Market Disposition | -4,259,689 | $35.35–35.78 |
| 2026-08-18 | James Boyle | Chief Executive Officer | Other Derivative Acquisition | +764,252 | $16.49 |
| 2026-08-18 | Stephen Miller | Former Chief Operating Officer | Other Derivative Acquisition | +87,667 | $19.01 |
| 2026-08-13 | GIC Private Limited | -- | Open Market Disposition | -1,600,000 | $35.80 |
| 2026-08-06 | GIC Private Limited | -- | Open Market Disposition | -590,284 | $35.58 |
| 2026-08-05 | GIC Private Limited | -- | Open Market Disposition | -2,248,612 | $35.33–36.48 |
| 2026-08-05 | Mozart Holdco, Inc. | -- | Other Disposition | -500,000 | -- |
| 2026-08-05 | Mozart Holdco, Inc. | -- | Derivative Exercise and Retained | +500,000 | -- |
| 2026-06-15 | Douglas Golwas | Chief Commercial Officer | Sale to Issuer | -100,000 | -- |
| 2026-06-15 | Douglas Golwas | Chief Commercial Officer | Derivative Exercise and Sale | -100,000 | $36.60–37.05 |
| 2026-06-14 | Michael Drazin | Chief Financial Officer | Sale to Issuer | -1,889 | $36.61 |
| 2026-06-14 | Christopher Shryock | Chief Human Resources Officer | Sale to Issuer | -872 | $36.61 |
| 2026-06-14 | Alex Liberman | Chief Legal Officer | Sale to Issuer | -872 | $36.61 |
| 2026-06-14 | Amanda Laabs | Chief Product Officer | Sale to Issuer | -1,889 | $36.61 |
| 2026-06-14 | James Boyle | Chief Executive Officer | Sale to Issuer | -2,370 | $36.61 |
| 2026-06-14 | Stephen Miller | Former Chief Operating Officer | Sale to Issuer | -1,889 | $36.61 |
| 2026-06-14 | Douglas Golwas | Chief Commercial Officer | Sale to Issuer | -1,889 | $36.61 |
| 2026-06-14 | William Abrams | Executive Vice President of Supply Chain Solutions | Sale to Issuer | -1,308 | $36.61 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Medline discussion 0 comments